Assura Regulatory News (AGR)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

19 August 2025

Assura plc ("Assura")

Board change

Assura announces that Ed Smith, CBE, Non-Executive Chair of Assura, has informed the company that he is resigning from his office as a director and Non-Executive Chair with immediate effect.

Ed Smith joined the Assura Board in 2017 and was appointed Chair in 2018. During his time as Chair he has provided critical oversight of Assura's strategy and governance, building on his extensive health service, public sector and business experience. Through his strong leadership of the board, Assura has been successful in delivering for its shareholders and its wider stakeholder group, including the National Health Service.

The board of directors of Assura notes the offer for Assura by Primary Health Properties PLC ("PHP"), which was declared wholly unconditional on 12 August 2025, and which currently remains open for acceptance until further notice. If PHP acquires Assura shares carrying 75 per cent. or more of the voting rights of Assura, PHP intends to procure the delisting and cancellation of trading of Assura's shares from the London Stock Exchange and the Johannesburg Stock Exchange.

In this context, the board of directors of Assura has appointed the Senior Non-Executive Director, Jonathan Davies, as Chair.

Jonathan Murphy, Chief Executive Officer of Assura, commented:

"We sincerely thank Ed for his huge contribution to the success of Assura over the past seven years. His guidance and support to me and the wider team has been invaluable. I know that I can speak for everyone in Assura in wishing him all the best for the future."

Jonathan Davies, Non-Executive Chair of Assura, commented:

"On behalf of the Board, I would like to thank Ed for his fantastic leadership and stewardship of the business during his term as Chair. Ed has played a vital role in driving Assura's performance and developing its long-term strategy, whilst never losing focus on its strong social purpose and the need to support the NHS. Both the Board and the wider business have been very fortunate to benefit from his deep knowledge and experience of the health sector. It has been a great privilege to work alongside Ed during all of his term as Chair and I now look forward to leading the Board during the CMA process."

Enquiries

Assura plc 0161 515 2043

Jonathan Murphy

Jayne Cottam

FGS Global (PR Adviser to Assura) 020 7251 3801

Gordon Simpson

Anjali Unnikrishnan

Grace Whelan

Inside Information

This Announcement contains inside information as defined in the UK version of the Market Abuse Regulation (EU) No 596/2014, which is part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this Announcement via a Regulatory Information Service, such inside information will be considered to be in the public domain.

The person responsible for arranging the release of this Announcement on behalf of Assura is Orla Ball, Company Secretary and General Counsel.